R. Nakagawa et al., Mechanisms of the antimetastatic effect in the liver and of the hepatocyteinjury induced by alpha-galactosylceramide in mice, J IMMUNOL, 166(11), 2001, pp. 6578-6584
The role of mouse liver NK1.1 Ag+ T (NKT) cells in the antitumor effect of
alpha -galactosylceramide (alpha -GalCer) has been unclear. We now show tha
t, whereas alpha -GalCer increased the serum IFN-gamma concentration and al
anine aminotransferase activity in NK cell-depleted C57BL/6 (B6) mice and B
6-beige/beige mice similarly to its effects in control B6 mice, its enhance
ment of the antitumor cytotoxicity of liver mononuclear cells (MNCs) was ab
rogated. Depletion of both NK and NKT cells In B6 mice reduced all these ef
fects of alpha -GalCer. Injection of Abs to IFN-gamma also inhibited the al
pha -GalCer-induced increase in antitumor cytotoxicity of MNCs. alpha -GalC
er induced the expression of Fas ligand on NKT cells in the liver of B6 mic
e. Whereas alpha -GalCer did not increase serum alanine aminotransferase ac
tivity in B6-lpr/lpr mice and B6-gld/gld mice, it increased the antitumor c
ytotoxicity of liver MNCs. The alpha -GalCer-induced increase in survival r
ate apparent in B6 mice injected intrasplenically with B16 tumor cells was
abrogated in beige/beige mice, NK cell-depleted B6 mice, and B6 mice treate
d with Abs to IFN-gamma. Depletion of CD8(+) T cells did not affect the alp
ha -GalCer-induced antitumor cytotoxicity of liver MNCs but reduced the eff
ect of alpha -GalCer on the survival of B6 mice. Thus, IFN-gamma produced b
y alpha -GalCer-activated NKT cells increases both the innate antitumor cyt
otoxicity of NK cells and the adaptive antitumor response of CD8(+) T cells
, with consequent inhibition of tumor metastasis to the liver. Moreover, NK
T cells mediate alpha -GalCer-induced hepatocyte injury through Fas-Fas lig
and signaling.